I think Bristol-Myers is an excellent takeover candidate. It has a bloated cost structure and some really good mid- to late-stage products.
I'd hate to bet against Mark Lanier. He knows how to beat them. I would say the odds are probably against Merck in this case.
The quarter was OK but I see no reason to buy the stock.
Off the top of my head, $1.3 billion sounds like a lot of money. I think it will be a billion dollar drug but it will take some time.
I think if they lose it really creates a negative vibe for the stock.
You are not going to be able to watch a television show without seeing a commercial for a sleeping pill.
Copyright © 2024 Electric Goat Media. All Rights Reserved.